JAZZ PHARMACEUTICALS PLC (JAZZ)
NASDAQ • Healthcare
Last close at August 11, 2026 at 20:00 UTC
Fundamentals Charts
About JAZZ PHARMACEUTICALS PLC
Jazz Pharmaceuticals plc is a biotechnology company listed on NASDAQ as JAZZ that develops and markets medicines for sleep disorders, epilepsy, and cancer across rare and specialty diseases. Its portfolio spans rare and specialty diseases, and the business generated $4.3 billion in FY2025 revenue.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
JAZZ PHARMACEUTICALS PLC's Technical Indicators Summary
JAZZ retains a buy profile because price sits above medium- and long-term moving averages, signaling an intact broader uptrend, while it has pulled back beneath short-term averages and the pivot, reflecting near-term weakness. ADX shows only moderate trend strength, MACD and RSI are neutral, volatility is steady, and on-balance volume is negative, which reduces conviction for the recent pullback. The combination suggests the larger trend remains constructive but short-term indicators and volume point to a corrective phase. Technical takeaway: Buy — medium/long-term trend intact though short-term indicators show a pullback.
| Indicator | Value |
|---|---|
RSI (14) | 51.54 |
Stochastic %K (14, 3, 3) | 31.51 |
CCI (20) | -65.08 |
WPR (14) | -65.17 |
Momentum (10) | -4.41 |
MFI | 52.60 |
MACD Level (12, 26) | 3.41 |
Bollinger Bands | $243.05 - $263.97 |
ATR (14) | $7.38 (2.93%) |
ADX (14) | 23.45 |
OBV | 39,394,116 |
Classic Pivot Point | $250.54 |
Fibonacci Pivot Point | $250.54 |
Simple Moving Averages | $196.14 - $255.53(5 indicators) |
Exponential Moving Averages | $197.94 - $254.06(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
JAZZ trades a touch higher, 1.31% above yesterday’s close (247.98). Volume has dried up to an unusually low 0.21× its norm. JAZZ to acquire Actio Biosciences, bolstering its epilepsy portfolio.
Trading Volume
Below 10d avg (956.5K)
205.2K
vs S&P 500 Today
Outperforming Market
+1.06%
52-Week Position
Near highs
90.9%
Updated: August 12, 2026 at 16:48 UTC